Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome

American Journal of Hematology

Volumn 85, Issue 6, 2010, Pages 431-434

  Stankowski Drengler, Trista ^a   Gertz, Morie A ^a   Katzmann, Jerry A ^a   Lacy, Martha Q ^a   Kumar, Shaji ^a   Leung, Nelson ^a   Hayman, Suzanne R ^a   Buadi, Francis ^a   Kyle, Robert A ^a   Rajkumar, S Vincent ^a   Dispenzieri, Angela ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY FAILURE; MALE; PLASMA CELL; PLASMACYTOSIS; POEMS SYNDROME; POLYCLONAL ACTIVATION; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; CLONE CELLS; CYSTATIN C; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; ILIUM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MIDDLE AGED; PLASMA CELLS; POEMS SYNDROME;

EID: 77953058368     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21707     Document Type: Article

References (13)

1. Dispenzieri A. POEMS Syndrome. Blood Rev 2007;21:285-299.
2. Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-680.
3. Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains. Clin Chem 2002 Sep;48:1437-1444.
4. Hutchison CA, Harding S, Hewins P, et al. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1684-1690.
5. Abadie JM, Van Hoeven KH, Wells JM. Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis? Am J Clin Pathol 2009 Feb; 131:166-171.
6. Gottenberg JE, Aucouturier F, Goetz J, et al. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Ann Rheum Dis 2007;66:23-27. (Pubitemid 46044856)
7. Rajkumar SV, Kyle RA, Therneau TM, et al. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Br J Haematol 2004;127:308-310.
8. Abraham RS, Katzmann JA, Clark RJ, et al. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol 2003;119:274-278.
9. Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001;97:2900-2902.
10. Dingli D, Kyle RA, Rajkumar SV, et al. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood 2006;108:1979-1983. (Pubitemid 44395010)
11. Dispenzieri A, Kyle RA, Katzmann JA, Therneau TM, Larson D, Benson J, et al. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood 2008;111:785-789.
12. Leleu X, Moreau AS, Weller E, Roccaro AM, Coiteux V, Manning R, et al. Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia. Leukemia Lymphoma 2008;49:1104-1107.
13. Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev clical Lab Sci 2004;41:467-550. (Pubitemid 39488773)